Annual report pursuant to Section 13 and 15(d)

SIGNIFICANT CONCENTRATIONS (Details)

v3.10.0.1
SIGNIFICANT CONCENTRATIONS (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2018
USD ($)
customer
item
Dec. 31, 2017
Dec. 31, 2016
SIGNIFICANT CONCENTRATIONS      
Number of specialty distributors | item 3    
Accounts receivable | $ $ 4,077    
Sales | Customer concentration risk | Kissei      
SIGNIFICANT CONCENTRATIONS      
Concentration risk as a percentage of revenue 69.00%    
Sales | Customer concentration risk | Three specialty distributors      
SIGNIFICANT CONCENTRATIONS      
Concentration risk as a percentage of revenue 31.00%    
Sales | Customer concentration risk | BerGenBio      
SIGNIFICANT CONCENTRATIONS      
Concentration risk as a percentage of revenue   74.00% 18.00%
Sales | Customer concentration risk | Third Party      
SIGNIFICANT CONCENTRATIONS      
Concentration risk as a percentage of revenue   26.00%  
Sales | Customer concentration risk | BMS      
SIGNIFICANT CONCENTRATIONS      
Concentration risk as a percentage of revenue     82.00%
Accounts receivable | Credit concentration risk      
SIGNIFICANT CONCENTRATIONS      
Concentration risk as a percentage of revenue 100.00%    
Number of customers | customer 3